In this week’s episode Patrick speaks to Quin Wills and Jack O’ Meara, Co-Founders of Ochre Bio, about their founding story, why in-silico discoveries could be the road to faster and lower cost liver therapeutics, and the need for prioritising preventative measures against disease as the average human lifetime gets longer.
EP 73: Ochre Bio: Building an in-silico liver model and addressing the impact and challenges of developing new treatments | The Genetics Podcast - Listen or read transcript on Metacast
